188 related articles for article (PubMed ID: 17948891)
1. Dopamine neurotransmission is involved in the attenuating effects of 5-HT3 receptor antagonist MDL 72222 on acute methamphetamine-induced locomotor hyperactivity in mice.
Yoo JH; Nam YS; Lee SY; Jang CG
Synapse; 2008 Jan; 62(1):8-13. PubMed ID: 17948891
[TBL] [Abstract][Full Text] [Related]
2. GABA(A) receptors mediate the attenuating effects of a 5-HT(3) receptor antagonist on methamphetamine-induced behavioral sensitization in mice.
Yoo JH; Lee HK; Kim HC; Lee SY; Jang CG
Synapse; 2010 Apr; 64(4):274-9. PubMed ID: 19953653
[TBL] [Abstract][Full Text] [Related]
3. Involvement of 5-HT receptors in the development and expression of methamphetamine-induced behavioral sensitization: 5-HT receptor channel and binding study.
Yoo JH; Cho JH; Yu HS; Lee KW; Lee BH; Jeong SM; Nah SY; Kim HC; Lee SY; Jang CG
J Neurochem; 2006 Nov; 99(3):976-88. PubMed ID: 16942594
[TBL] [Abstract][Full Text] [Related]
4. Effects of repeated daily treatments with a 5-HT3 receptor antagonist on dopamine neurotransmission and functional activity of 5-HT3 receptors within the nucleus accumbens of Wistar rats.
Liu W; Thielen RJ; McBride WJ
Pharmacol Biochem Behav; 2006 Jun; 84(2):370-7. PubMed ID: 16828150
[TBL] [Abstract][Full Text] [Related]
5. 5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat.
Kankaanpää A; Meririnne E; Seppälä T
Psychopharmacology (Berl); 2002 Feb; 159(4):341-50. PubMed ID: 11823886
[TBL] [Abstract][Full Text] [Related]
6. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
[TBL] [Abstract][Full Text] [Related]
7. Suppressive effects of trihexyphenidyl on methamphetamine-induced dopamine release as measured by in vivo microdialysis.
Shimosato K; Nagao N; Watanabe S; Kitayama S
Synapse; 2003 Jul; 49(1):47-54. PubMed ID: 12710014
[TBL] [Abstract][Full Text] [Related]
8. Serotonergic involvement in methamphetamine-induced locomotor activity: a detailed pharmacological study.
Steed E; Jones CA; McCreary AC
Behav Brain Res; 2011 Jun; 220(1):9-19. PubMed ID: 21262272
[TBL] [Abstract][Full Text] [Related]
9. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
[TBL] [Abstract][Full Text] [Related]
10. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations.
Joyce JN; Renish L; Osredkar T; Walro JM; Kucera J; Dluzen DE
Synapse; 2004 Apr; 52(1):11-9. PubMed ID: 14755628
[TBL] [Abstract][Full Text] [Related]
11. Role of prefrontal dopaminergic neurotransmission in glucocorticoid receptor-mediated modulation of methamphetamine-induced hyperactivity.
Ago Y; Arikawa S; Yata M; Yano K; Abe M; Takuma K; Matsuda T
Synapse; 2009 Jan; 63(1):7-14. PubMed ID: 18925659
[TBL] [Abstract][Full Text] [Related]
12. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
Shuto T; Kuroiwa M; Hamamura M; Yabuuchi K; Shimazoe T; Watanabe S; Nishi A; Yamamoto T
Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine-induced hyperactivity and behavioral sensitization in PACAP deficient mice.
Fujii H; Ishihama T; Ago Y; Shintani N; Kakuda M; Hashimoto H; Baba A; Matsuda T
Peptides; 2007 Sep; 28(9):1674-9. PubMed ID: 17658665
[TBL] [Abstract][Full Text] [Related]
14. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
Dhir A; Kulkarni SK
Brain Res Bull; 2007 Sep; 74(1-3):58-65. PubMed ID: 17683790
[TBL] [Abstract][Full Text] [Related]
15. Involvement of dopamine, N-methyl-D-aspartate and sigma receptor mechanisms in methamphetamine-induced anticipatory activity rhythm in rats.
Shibata S; Ono M; Fukuhara N; Watanabe S
J Pharmacol Exp Ther; 1995 Aug; 274(2):688-94. PubMed ID: 7636729
[TBL] [Abstract][Full Text] [Related]
16. Effects of tetrabenazine on methamphetamine-induced hyperactivity in mice are dependent on order and time-course of administration.
Kuribara H
Pharmacol Biochem Behav; 1997 Jan; 56(1):9-14. PubMed ID: 8981603
[TBL] [Abstract][Full Text] [Related]
17. Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization.
Chen PC; Lao CL; Chen JC
J Neurochem; 2007 Jan; 100(1):225-41. PubMed ID: 17101033
[TBL] [Abstract][Full Text] [Related]
18. Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine.
Ke JJ; Chen HI; Jen CJ; Kuo YM; Cherng CG; Tsai YP; Ho MC; Tsai CW; Yu L
Toxicol Appl Pharmacol; 2008 Mar; 227(2):239-47. PubMed ID: 18076959
[TBL] [Abstract][Full Text] [Related]
19. Involvement of some 5-HT receptors in methamphetamine-induced locomotor activity in mice.
Ginawi OT; Al-Majed AA; Al-Suwailem AK; El-Hadiyah TM
J Physiol Pharmacol; 2004 Jun; 55(2):357-69. PubMed ID: 15213358
[TBL] [Abstract][Full Text] [Related]
20. 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants.
Auclair A; Drouin C; Cotecchia S; Glowinski J; Tassin JP
Eur J Neurosci; 2004 Dec; 20(11):3073-84. PubMed ID: 15579162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
